San Giovanni Battista Hospital, Turin Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2006
NCT00370253
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Division of Gastroenterology and Hepatology, San Giovanni Battista Hospital, Turin, Italy

Active Ingredients

Drugs in Phase 3 Trials (2)

norepinephrine (levophed) (1 trial)

terlipressin (Terlivaz) (1 trial)

Drugs in Phase 2 Trials (1)

albumin (Human) (Plasbumin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ascites (Phase 2)

Fibrosis (Phase 2)

Hepatorenal Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3